A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...
Celcuity Inc. soared on best-in-class Phase 3 breast cancer data. Click to see why I have a Buy rating on CELC due to data, regulatory filings, and potential M&A.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback